{"prompt": "['Acupuncture for Chemotherapy-Induced Peripheral Neuropathy Among Cancer Patients', 'Wake Forest Baptist Comprehensive Cancer Center (WFBCCC)', 'CCCWFU # 97118', 'George Yacoub, MD', 'Section on Hematology and Oncology', 'Wake Forest School of Medicine', 'Medical Center Boulevard', 'Winston-Salem, NC 27157', 'Biostatistician:', 'Janet Tooze, PhD, Professor', 'Biostatistical Sciences', 'Wake Forest School of Medicine', 'Medical Center Boulevard', 'Winston-Salem, NC 27157', 'Research Nurses:', 'Angela Howell', 'Wake Forest Baptist Comprehensive Cancer Center', 'Medical Center Blvd', 'Winston-Salem, NC 27157', 'Heather Kirby', 'Wake Forest Baptist Comprehensive Cancer Center', 'Medical Center Blvd', 'Winston-Salem, NC 27157', 'Study Coordinator:', 'Kelsey Shore', 'Community Research Coordinator', 'Office of Cancer Health Equity', 'Wake Forest Baptist Comprehensive Cancer Center', 'Medical Center Blvd', 'Winston-Salem, NC 27157', 'Laura Hayes, RN', 'High Point Nursing Clinical Research Manager', 'Hayworth Cancer Center 302 Westwood Avenue', 'High Point, NC 27262', 'Sheri Whittington', 'High Point Oncology Admin', 'Hayworth Cancer Center 302 Westwood Avenue', 'High Point, NC 27262', 'Regulatory Contact:', 'Emily Teal', 'Wake Forest Baptist Comprehensive Cancer Center', 'Medical Center Blvd', 'Page iv of 55']['Acupuncture for Chemotherapy-Induced Peripheral Neuropathy Among Cancer Patients', 'Wake Forest Baptist Comprehensive Cancer Center (WFBCCC)', 'CCCWFU # 97118', 'Winston-Salem, NC 27157', 'Protocol Editor:', 'Mac Robinson, PhD', 'Wake Forest Baptist Comprehensive Cancer Center', 'Winston-Salem, NC 27157', 'Dermatology Pathology', 'Fellow:', 'Christine Ahn, MD', 'Winston-Salem, NC 27157', 'Participating Institution(s):', 'Wake Forest Baptist Medical Center', 'Version Date:', '10/21/20', 'Confidential', 'Page V of 55']['Acupuncture for Chemotherapy-Induced Peripheral Neuropathy Among Cancer Patients', 'Wake Forest Baptist Comprehensive Cancer Center (WFBCCC)', 'CCCWFU # 97118', 'Table of Contents', 'Schema', '1', '1.0', 'Introduction and Background', '2', '2.0', 'Objectives', '5', '2.1 Primary Objective', '5', '2.2.', 'Secondary Objectives', '6', '2.3.', 'Exploratory Objectives', '6', '3.0', 'Study Population', '6', '3.1', 'Inclusion Criteria', '7', '3.2', 'Exclusion Criteria', '7', '3.3', 'Inclusion of women and minorities', '7', '4.0', 'Methods', '8', '4.1', 'Registration Procedures', '8', '4.2 Study Activities', '9', '4.3', 'Study setting', '10', '4.4', 'Enrollment and Screening', '10', '4.5', 'Peripheral Nerve Assessment', '11', '4.6', 'Randomization', '12', '4.7', 'Intervention: Acupuncture Treatments', '13', '4.8', 'Week 12 End of Treatment Assessment', '13', '4.9', 'Acupuncture for Usual Care Control Group', '13', '5.0', 'Adverse Events List and Reporting Requirements', '13', '5.1', 'Adverse Event List for Acupuncture', '13', '5.2', 'Adverse Event List for Nerve Conduction Studies', '14', '5.3', 'Adverse Event List for Biopsies', '14', '5.4', 'Adverse Event List for Ultrasound', '14', '5.5', 'Adverse Event Characteristics', '14', '5.6', 'STRC SAE Reporting Requirements', '14', '5.7', 'WFUHS IRB AE Reporting Requirements', '15', '6.0', 'Duration of Follow-up', '15', '7.0', 'Outcome Measures', '16', '7.1', 'Primary Outcome', '16', '7.2', 'Secondary Outcomes', '16', '7.3', 'Covariates', '16', '8.0', 'Statistical Considerations', '17', '8.1', 'Sample Size and Power', '17', '8.2', 'Analysis of Primary Objective', '17', '8.3', 'Analysis of Secondary Objectives', '17', 'Page vi of 55']\n\n###\n\n", "completion": "END"}